Kodiak Sciences Inc KOD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
3.33UNCH (UNCH)
Volume
1,112
Close
3.33quote price arrow down-0.09 (-2.63%)
Volume
325,675
52 week range
1.37 - 9.80
Loading...
  • Open3.43
  • Day High3.56
  • Day Low3.33
  • Prev Close3.42
  • 52 Week High9.80
  • 52 Week High Date06/07/23
  • 52 Week Low1.37
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap174.854M
  • Shares Out52.51M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.24
  • YTD % Change9.54

KEY STATS

  • Open3.43
  • Day High3.56
  • Day Low3.33
  • Prev Close3.42
  • 52 Week High9.80
  • 52 Week High Date06/07/23
  • 52 Week Low1.37
  • 52 Week Low Date10/27/23
  • Market Cap174.854M
  • Shares Out52.51M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.24
  • YTD % Change9.54

RATIOS/PROFITABILITY

  • EPS (TTM)-4.97
  • P/E (TTM)-0.67
  • Fwd P/E (NTM)-0.82
  • EBITDA (TTM)-259.023M
  • ROE (TTM)-74.22%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kodiak Sciences Inc

 

Profile

MORE
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high...
Victor Perlroth M.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
John Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Address
1200 PAGE MILL RD
Palo Alto, CA
94304
United States

Top Peers

SYMBOLLASTCHG%CHG
GOSS
Gossamer Bio Inc
0.7376-0.0054-0.7268%
DRTS
Alpha Tau Medical Ltd
2.50+0.06+2.46%
ATOS
Atossa Therapeutics Inc
1.49+0.07+4.93%
ELEV
Elevation Oncology Inc
4.32+0.27+6.67%
INO
Inovio Pharmaceuticals Inc
10.37+0.35+3.49%